Full Year 2025 DSM-Firmenich AG Earnings Call Transcript
Key Points
- DSM-Firmenich AG (DSMFF) reported a 3% organic sales growth in 2025 despite a challenging market environment.
- The company successfully divested its ANH business to CBC, mitigating downside risks and securing a favorable long-term supply agreement on vitamins.
- DSM-Firmenich AG (DSMFF) maintained a stable dividend at 250, demonstrating confidence in its financial stability.
- The company achieved a 19.6% EBITDA margin in 2025, with a trajectory towards 20% in the second half of the year.
- DSM-Firmenich AG (DSMFF) is committed to sustainability, achieving 100% renewable energy ahead of schedule and receiving high ratings for climate and water initiatives.
- The company experienced a cautious consumer behavior, particularly in North America, impacting its taste and health segments.
- DSM-Firmenich AG (DSMFF) faced a decline in cash conversion, down to 10.5% from the previous year, partly due to elevated inventory levels.
- The perfumery and beauty segment saw a margin decline due to negative mix effects and currency impacts.
- The company did not provide a detailed 2026 outlook during the earnings call, leading to some uncertainty among investors.
- DSM-Firmenich AG (DSMFF) is still managing the transition and separation costs from its recent divestments, which could impact short-term financials.
Good morning and thank you for joining today's call. I'm sitting here with Dimitri de Fraser, our CEO, and Ralph Smits, our CEO.
This morning we published our full year 2025 results on a restated basis, together with a presentation to investors which you can find on our website. Here you can also find our disclaimers about forward-looking statements. Following Dimitri's and Rolf's opening comments, we will open the line for questions, and as usual, as a reminder, the cell site analysts who want to ask questions will need to register via the questioners link, which they can find on the website in the financial calendar.
Dmitri, the floor is yours.
Thank you, Dave and welcome to everybody here in this call. Nice to see you yet again. A busy week for us, busy week for you. The NH call last Monday, now the full year results and you've seen that, there are a lot of numbers
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

